Research and Markets: Asia-Pacific Infusion Therapy Device Market - Executive Summary Report 2014

Research and Markets (http://www.researchandmarkets.com/research/tnc4q4/asiapacific) has announced the addition of the "Asia-Pacific Infusion Therapy Device Market (Executive Summary)" report to their offering.

Infusion pumps represent an established and integrated component of the medical system. As a result, the rise in demand for these devices is proportional to the number of people that require medical care each year. For example, the population in Australia in 2013 was growing at approximately 2% per year, but the age of people over 65 years of age was increasing at a faster rate.

A trend in the region toward higher usage rates of pump intravenous (IV) sets and mechanical needleless connectors will serve to provide growth in the segments.

As electronic medical records and smart pumps increase their penetration into the Asia-Pacific markets, the overall market value is expected to increase as well.

Key Topics Covered:

  1. Asia-Pacific Infusion Therapy Device Market
  2. Volumetric Infusion Pump Market
  3. Syringe Infusion Pump Market
  4. Disposable Infusion Pump Market
  5. Intravenous and Extension Set Market
  6. Needleless Connector Market
  7. Competitive Analysis

Companies Mentioned

  • B. Braun
  • Baxter International
  • Becton Dickinson
  • CareFusion
  • Codan, Covidien
  • Fresenius
  • Go Medical
  • Hospira
  • I-Flow
  • ICU Medical
  • Nipro Medical
  • Smiths Medical
  • TUTA
  • Terumo

For more information visit http://www.researchandmarkets.com/research/tnc4q4/asiapacific

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.